Conference Coverage

PSYCHIATRY UPDATE 2016


 

Anxiety Disorders in Women Across the Lifecycle
Marlene P. Freeman, MD, Massachusetts General Hospital

Almost one-third of women will meet criteria for an anxiety disorder during their lifetime, and symptoms can become worse during pregnancy and the postpartum period. Postpartum obsessions and psychosis can be difficult to distinguish, but the key is insight. Psychotherapy is first-line treatment for mild to moderate anxiety during pregnancy, but medication plus psychotherapy is indicated for severe cases. Antidepressants are considered compatible with breast-feeding, although the long half-life of fluoxetine means higher concentrations in breast milk. During menopause, women with preexisting anxiety may be more susceptible to the development of anxiety disorders. Serotonergic antidepressants, as well as gabapentin, have evidence of efficacy for hot flashes. A diagnosis of premenstrual dysphoric disorder (PMDD) indicates significant psychiatric morbidity that interferes with function, not an underlying psychiatric disorder that gets worse premenstrually. Ask patients to track their moods, especially while they are trying different treatments. Treating PMDD with serotonergic antidepressants has been well researched.

Pages

Recommended Reading

FDA announces new plan to combat opioid abuse
MDedge Psychiatry
NIDA releases strategic plan to prevent, treat substance use disorders
MDedge Psychiatry
ThriveNYC could help treat and destigmatize mental, behavioral disorders
MDedge Psychiatry
Designer drug symptoms can mimic schizophrenia, anxiety, depression
MDedge Psychiatry
Opioid prescribing: An odyssey of challenges
MDedge Psychiatry
Opiate drug detox appears safe in pregnancy
MDedge Psychiatry
Pot tied to increased risk of substance use disorders, not depression or anxiety
MDedge Psychiatry
We are not ‘psychiatrists’; 'The beauty of the asylum’; Challenges with false-positive urine drug screens
MDedge Psychiatry
Marijuana tourists also visiting Colorado EDs
MDedge Psychiatry
VIDEO: How proposed patient substance use privacy rule impacts physicians
MDedge Psychiatry